Dermata Therapeutics Inc.

0.91
-0.02 (-2.38%)
At close: Apr 04, 2025, 10:16 AM

Dermata Therapeutics Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for DRMA stock have an median target of 6, with a low estimate of 6 and a high estimate of 6. The median target predicts an increase of 559.34% from the current stock price of 0.91.

Target Low Average Median High
Price $6 $6 $6 $6
Change 559.34% 559.34% 559.34% 559.34%

Latest Analyst Insight Report

According to 1 stock analyst, the rating for Dermata Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Aug 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
15M
from 0
Increased by -%
EPS This Year
-1
from -8032.22
Increased by 100.0%
EPS Next Year
-1.02
from -1
Increased by -2%